scorecardresearch
Tuesday, July 29, 2025
TopicFDA

Topic: FDA

Tariff cloud looming, US study links Indian generic drugs with 54% higher severe adverse events

Researchers associated with The Ohio State University found that number of severe adverse events linked to generic drugs made in India was 54% higher than for those made in the US.

Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.

1st US FDA-approved drug invented in India set for local launch as part of combination antibiotic

Combination of enmetazobactam, invented by scientists associated with Chennai-based pharma firm Orchid Pharma in 2008, and antibiotic cefipime is used to treat severe bacterial infection.

‘Ban McDonald’s nationwide,’ says traders’ body after ‘fake cheese’ found in burger in Maharashtra

Such fraudulent practices cannot be tolerated, CAIT adds. This comes after Food & Drug Administration allegedly found counterfeit cheese at fast food giant's outlet in Ahmednagar.

US cracks down on healthcare product makers following cough syrup deaths overseas

Cough syrups made in India & Indonesia have been linked to deaths of over 300 children globally. Medicines were found to contain high levels of DEG, EG, leading to death.

Op Broader Sword: India, US join hands to crack down on shipments of ‘illicit’ drugs, medical devices

Operation targeted packages entering US from India through New York (JFK) & Chicago (ORD) International Mail Facilities (IMFs) last month. Over 500 shipments seized, Indian national held.

After Singapore, US now approves sale of lab-grown meat in restaurants, grocery stores

The US government’s approval to two California-based companies is being seen as a huge step for the alternative protein industry.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

US FDA takes new dengue vaccine by Japanese firm Takeda for priority review

Takeda has carried out phase 3 trials of the vaccine candidate and found it to be 80.2% effective in preventing symptomatic dengue cases after a year of vaccination.

‘No prescription sought, drugs under different names’ — Maharashtra FDA busts ‘abortion pill racket’

FDA officers in 13 parts of the state posed as customers and managed to easily procure the kits. FIRs lodged against e-commerce app, ‘unlicensed’ agency.

On Camera

Dhankhar’s resignation: How Modi-Shah’s ‘capable’ BJP has served another strong message to RSS

One has to be incredibly credulous to buy BJP spin masters’ argument that the government got rid of Vice President Jagdeep Dhankhar for harmonious relationship with the judiciary.

Unclaimed deposits worth Rs 67,000 crore lying in banks, 87% in public sector banks alone, Parliament told

SBI holds Rs 19,239 crore in unclaimed deposits, or 26% of the abandoned money in public banking system. PNB, Canara Bank follow.

India wanted a stable, prosperous Pakistan but our peace efforts were mistaken for weakness: Rajnath

Modi government had also made numerous efforts to establish peace with Pakistan but has now adopted a different path, militarily, to establish peace, adds defence minister.

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.